FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Stephen Kemp

Research Profile

Chemicals & Drugs

Disorders

Concepts & Ideas

Anatomy

Physiology

Co-author Network

Publications

TOP 3
Kathryn M Thrailkill; Kathy Edwards; J Paul Frindik; Stephen Kemp; Alba E Morales; Cynthia S Moreau; Mallik Rettiganti; Christopher Swearingen; John L Fowlkes
Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.
Stephen Kemp; J Paul Frindik
Emerging options in growth hormone therapy: an update.
J Paul Frindik; Stephen Kemp
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Stephen Kemp (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2011: Kathryn M Thrailkill; Kathy Edwards; J Paul Frindik; Stephen Kemp; Alba E Morales; Cynthia S Moreau; Mallik Rettiganti; Christopher Swearingen; John L Fowlkes
Insulin pump therapy started at the time of diagnosis: effects on glycemic control and pancreatic β-cell function in type 1 diabetes.
Diabetes technology & therapeutics 2011;13(10):1023-30.
2011: Stephen Kemp; J Paul Frindik
Emerging options in growth hormone therapy: an update.
Drug design, development and therapy 2011;5():411-9.
2010: J Paul Frindik; Stephen Kemp
Managing idiopathic short stature: role of somatropin (rDNA origin) for injection.
Biologics : targets & therapy 2010;4():147-55.
2009: David M Cook; Kevin C J Yuen; Beverly M K Biller; Stephen Kemp; Mary Lee Vance
American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2009;15 Suppl 2():1-29.
2009: David M Cook; Kevin C J Yuen; Beverly M K Biller; Stephen Kemp; Mary Lee Vance
American Association of Clinical Endocrinologists medical guidelines for clinical practice for growth hormone use in growth hormone-deficient adults and transition patients - 2009 update: executive summary of recommendations.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2009;15(6):580-6.
2009: J Paul Frindik; Alba Morales; John Fowlkes; Stephen Kemp; Kathryn Thrailkill; Barbara Lippe; Ken Dana
Stimulant medication use and response to growth hormone therapy: an NCGS database analysis.
Hormone research 2009;72(3):160-6.
2009: Stephen Kemp
Insulin-like growth factor-I deficiency in children with growth hormone insensitivity: current and future treatment options.
BioDrugs : clinical immunotherapeutics, biopharmaceuticals and gene therapy 2009;23(3):155-63.
2007: Kathryn M Thrailkill; Robert C Bunn; Cynthia S Moreau; Gael E Cockrell; Pippa M Simpson; Hannah N Coleman; J Paul Frindik; Stephen Kemp; John L Fowlkes
Matrix metalloproteinase-2 dysregulation in type 1 diabetes.
Diabetes care 2007;30(9):2321-6.
2007: Dana S Hardin; Stephen Kemp; David B Allen
Twenty years of recombinant human growth hormone in children: relevance to pediatric care providers.
Clinical pediatrics 2007;46(4):279-86.
2007: Teresa A Nimmo; Alba E Morales; Kadria Sayed; J Paul Frindik; Stephen Kemp
Hypercalcemia in an 11-year-old girl.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2007;13(2):198-201.
2007: Stephen Kemp
Mecasermin rinfabate.
Drugs of today (Barcelona, Spain : 1998) 2007;43(3):149-55.
2007: Dorothy I Shulman; Mark R Palmert; Stephen Kemp
Adrenal insufficiency: still a cause of morbidity and death in childhood.
Pediatrics 2007;119(2):e484-94.
2006: Stephen Kemp; John L Fowlkes; Kathryn M Thrailkill
Efficacy and safety of mecasermin rinfabate.
Expert opinion on biological therapy 2006;6(5):533-8.
2006: Stephen Kemp; Kathryn M Thrailkill
Investigational agents for the treatment of growth hormone-insensitivity syndrome.
Expert opinion on investigational drugs 2006;15(4):409-15.
2005: Phyllis W Speiser; Cheril L Clarson; Erica A Eugster; Stephen Kemp; Sally Radovick; Alan D Rogol; Thomas A Wilson
Bisphosphonate treatment of pediatric bone disease.
Pediatric endocrinology reviews : PER 2005;3(2):87-96.
2005: Kathryn M Thrailkill; Charles K Lumpkin; Robert C Bunn; Stephen Kemp; John L Fowlkes
Is insulin an anabolic agent in bone? Dissecting the diabetic bone for clues.
American journal of physiology. Endocrinology and metabolism 2005;289(5):E735-45.
2005: Stephen Kemp; Joyce Kuntze; Kenneth M Attie; Thomas Maneatis; S Butler; James Frane; Barbara Lippe
Efficacy and safety results of long-term growth hormone treatment of idiopathic short stature.
The Journal of clinical endocrinology and metabolism 2005;90(9):5247-53.
2005: Stephen Kemp
Growth hormone treatment of idiopathic short stature: history and demographic data from the NCGS.
Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society 2005;15 Suppl A():S9-12.
2005: Stephen Kemp; Kathryn M Thrailkill
SomatoKine: is there a use in treating growth disorders?
Current opinion in investigational drugs (London, England : 2000) 2005;6(4):373-7.
2005: Stephen Kemp
Height and social adjustment.
Pediatrics 2005;115(2):515-6; author reply 516-7.
2004: Stephen Kemp; Paul Fielder; Kenneth M Attie; Sandra L Blethen; Edward O Reiter; Kathleen M Ford; M Marian; Le Dao; H J Lee; Paul Saenger
Pharmacokinetic and pharmacodynamic characteristics of a long-acting growth hormone (GH) preparation (nutropin depot) in GH-deficient children.
The Journal of clinical endocrinology and metabolism 2004;89(7):3234-40.
2003: Thomas A Wilson; Susan R Rose; Pinchas Cohen; Alan D Rogol; Philippe Backeljauw; Rosalind Brown; Dana S Hardin; Stephen Kemp; Margaret Lawson; Sally Radovick; Stephen M Rosenthal; Lawrence Silverman; Phyllis Speiser
Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee.
The Journal of pediatrics 2003;143(4):415-21.
2003: J Paul Frindik; Stephen Kemp; J J Hunold
Near adult heights after growth hormone treatment in patients with idiopathic short stature or idiopathic growth hormone deficiency.
Journal of pediatric endocrinology & metabolism : JPEM 2003;16 Suppl 3():607-12.
2002: Stephen Kemp; Craig A Alter; Ken Dana; Joyce Baptista; Sandra L Blethen
Use of magnetic resonance imaging in short stature: data from National Cooperative Growth Study (NCGS) Substudy 8.
Journal of pediatric endocrinology & metabolism : JPEM 2002;15 Suppl 2():675-9.
2001: Edward O Reiter; Kenneth M Attie; T Moshang; Bernard L Silverman; Stephen Kemp; R B Neuwirth; Kathleen M Ford; Paul Saenger
A multicenter study of the efficacy and safety of sustained release GH in the treatment of naive pediatric patients with GH deficiency.
The Journal of clinical endocrinology and metabolism 2001;86(10):4700-6.
1999: Patrick G Brosnan; Christine A Brosnan; Stephen Kemp; D B Domek; D H Jelley; P R Blackett; WJ Riley
Effect of newborn screening for congenital adrenal hyperplasia.
Archives of pediatrics & adolescent medicine 1999;153(12):1272-8.
1999: Stephen Kemp; J P Sy
Analysis of bone age data from national cooperative growth study substudy VII.
Pediatrics 1999;104(4 Pt 2):1031-6.
1999: J Paul Frindik; Stephen Kemp; J P Sy
Effects of recombinant human growth hormone on height and skeletal maturation in growth hormone-deficient children with and without severe pretreatment bone age delay.
Hormone research 1999;51(1):15-9.
1998: Allen W Root; Stephen Kemp; A C Rundle; K Dana; Kenneth M Attie
Effect of long-term recombinant growth hormone therapy in children--the National Cooperative Growth Study, USA, 1985-1994.
Journal of pediatric endocrinology & metabolism : JPEM 1998;11(3):403-12.
1997: Eileen N Ellis; Bradley A Warady; Ellen G Wood; R Hassanein; W P Richardson; PH Lane; C Howard; Stephen Kemp; T Aceto; L Garibaldi; Thomas B Wiegmann; Virginia J Savin
Renal structural-functional relationships in early diabetes mellitus.
Pediatric nephrology (Berlin, Germany) 1997;11(5):584-91.
1997: M J Elders; CR Scott; J Paul Frindik; Stephen Kemp
Clinical workup for precocious puberty.
Lancet 1997;350(9076):457-8.
1996: C R Scott; J Paul Frindik; Stephen Kemp; Gregory L Kearns
Recurrent hypoglycemia and obesity in an adolescent--insulinoma or imitator?
Clinical pediatrics 1996;35(3):157-60.
1996: J Paul Frindik; Stephen Kemp; C Pihoker
Effective use of magnetic resonance imaging in the assessment of children with possible growth hormone deficiency.
Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 1996;2(1):8-12.
1995: Keith M Olsen; G L Kearns; Stephen Kemp
Glyburide protein binding and the effect of albumin glycation in children, young adults, and older adults with diabetes.
Journal of clinical pharmacology 1995;35(7):739-45.
1993: Stephen Kemp; J Paul Frindik; Gregory L Kearns
Clinical and biochemical correlates of growth associated with short-term administration of methionyl growth hormone.
Developmental pharmacology and therapeutics 1993;20(3-4):199-204.
1992: J Paul Frindik; Stephen Kemp; F S Kearns; B Hale
Growth screening. A positive medical experience.
Clinical pediatrics 1992;31(8):497-500.
1991: J K Smith; Stephen Kemp
Pseudohypoaldosteronism: successful treatment with home electrolyte monitoring.
Clinical pediatrics 1991;30(10):600-1.
1991: Stephen Kemp; J Paul Frindik
Effect of metabolic control on serum protein concentrations in diabetes.
Acta paediatrica Scandinavica 1991;80(10):938-43.
1991: Gregory L Kearns; Stephen Kemp; J Paul Frindik
Single and multiple dose pharmacokinetics of methionyl growth hormone in children with idiopathic growth hormone deficiency.
The Journal of clinical endocrinology and metabolism 1991;72(5):1148-56.
1991: Eileen N Ellis; Stephen Kemp; J Paul Frindik; M J Elders
Glomerulopathy in patient with Donohue syndrome (leprechaunism).
Diabetes care 1991;14(5):413-4.
1991: May L Griebel; J F Redman; Stephen Kemp; M J Elders
Hypertrophy of clitoral hood: presenting sign of neurofibromatosis in female child.
Urology 1991;37(4):337-9.
1990: L M Hu; Stephen Kemp; C F Peng; M J Elders; W G Smith
Effects of dideoxyforskolin on proteoglycan synthesis and structure in embryonic chick chondrocyte cultures.
FEBS letters 1990;270(1-2):100-4.
1990: KV Sitz; A Wesley Burks; Larry W Williams; Stephen Kemp; R W Steele
Confirmation of X-linked hypogammaglobulinemia with isolated growth hormone deficiency as a disease entity.
The Journal of pediatrics 1990;116(2):292-4.
1990: L M Hu; Stephen Kemp; M J Elders; W G Smith
Effect of forskolin on synthesis of xyloside-initiated glycosaminoglycans in embryonic chick chondrocytes.
Biochimica et biophysica acta 1990;1051(1):112-4.
1990: B A Kostic; Keith M Olsen; G L Kearns; Stephen Kemp
Effect of glycated albumin on phenytoin binding in elderly patients with type II diabetes mellitus.
Pharmacotherapy 1990;10(5):362-5.
1989: L M Hu; Stephen Kemp; M J Elders; W G Smith
Metabolic effects of forskolin in chick chondrocytes.
Biochimica et biophysica acta 1989;1013(3):294-9.
1988: Stephen Kemp; G L Kearns; W G Smith; M J Elders
Effects of IGF-I on the synthesis and processing of glycosaminoglycan in cultured chick chondrocytes.
Acta endocrinologica 1988;119(2):245-50.
1988: Gregory L Kearns; Stephen Kemp; C P Turley; D L Nelson
Protein binding of phenytoin and lidocaine in pediatric patients with type I diabetes mellitus.
Developmental pharmacology and therapeutics 1988;11(1):14-23.
1987: K R Rettig; D T Sargeant; Stephen Kemp
Resistance to the effects of thyroid hormone in children.
Southern medical journal 1987;80(10):1316-8.
1987: Stephen Kemp; Gregory L Kearns; C P Turley
Alteration of phenytoin binding by glycosylation of albumin in IDDM.
Diabetes 1987;36(4):505-9.
1987: D L Vesely; Stephen Kemp; M J Elders
Isolation of a biotin receptor from hepatic plasma membranes.
Biochemical and biophysical research communications 1987;143(3):913-6.
1986: Stephen Kemp; M E Canfield; F S Kearns; M J Elders
The effect of short-term intervention on long-term diabetes management.
The Journal of the Arkansas Medical Society 1986;83(6):241-4.
1986: D L Vesely; H K Schedewie; Stephen Kemp; J Paul Frindik; M J Elders
Decreased cyclic guanosine 3',5' monophosphate and guanylate cyclase activity in leprechaunism: evidence for a postreceptor defect.
Pediatric research 1986;20(4):329-31.
1986: S Eichold; Stephen Kemp; P T Hennessey
Graded Smelo response as a measure of neurologic integrity and glycemia status of children with diabetes mellitus.
Alabama medicine : journal of the Medical Association of the State of Alabama 1986;55(7):35-8.
1985: J Paul Frindik; Stephen Kemp; R H Fiser; H Schedewie; M J Elders
Phenotypic expression in Donohue syndrome (leprechaunism): a role for epidermal growth factor.
The Journal of pediatrics 1985;107(3):428-30.
1985: M S Bolze; R D Reeves; F E Lindbeck; Stephen Kemp; M J Elders
Influence of manganese on growth, somatomedin and glycosaminoglycan metabolism.
The Journal of nutrition 1985;115(3):352-8.
1985: M E Canfield; Stephen Kemp; C Hoff
Assessment of a new blood glucose strip: comparison of Visidex, Visidex II, and Chemstrip bG with Glucose Analyzer determination of blood glucose.
Diabetes care 1985;8(1):77-82.
1984: Stephen Kemp; M Mutchnick; R L Hintz
Hormonal control of protein synthesis in chick chondrocytes: a comparison of effects of insulin, somatomedin C and triiodothyronine.
Acta endocrinologica 1984;107(2):179-84.
1984: Stephen Kemp; R H Creech; T R Horn
Glycosylated albumin and transferrin: short-term markers of blood glucose control.
The Journal of pediatrics 1984;105(3):394-8.
1983: Stephen Kemp; M E Canfield
Acute effects of growth hormone administration: vitamin A and visceral protein concentrations.
Acta endocrinologica 1983;104(4):390-6.
1983: J Paul Frindik; D A Kassner; D A Pirkle; Stephen Kemp; C Hoff
Comparison of Visidex and Chemstrip bG with Beckman Glucose Analyzer determination of blood glucose.
Diabetes care 1983;6(6):536-9.
1981: J M Horner; Stephen Kemp; R L Hintz
Growth hormone and somatomedin in insulin-dependent diabetes mellitus.
The Journal of clinical endocrinology and metabolism 1981;53(6):1148-53.
1981: Ronald G Rosenfeld; Stephen Kemp; R L Hintz
Constancy of somatomedin response to growth hormone treatment of hypopituitary dwarfism, and lack of correlation with growth rate.
The Journal of clinical endocrinology and metabolism 1981;53(3):611-7.
1981: R L Hintz; F Liu; Ronald G Rosenfeld; Stephen Kemp
Plasma somatomedin-binding proteins in hypopituitarism: changes during growth hormone therapy.
The Journal of clinical endocrinology and metabolism 1981;53(1):100-4.
1981: Stephen Kemp; Ronald G Rosenfeld; F Liu; S Gaspich; R L Hintz
Acute somatomedin response to growth hormone: radioreceptor assay versus radioimmunoassay.
The Journal of clinical endocrinology and metabolism 1981;52(4):616-21.
1981: Ronald G Rosenfeld; Stephen Kemp; S Gaspich; R L Hintz
In vivo modulation of somatomedin receptor sites: effects of growth hormone treatment of hypopituitary children.
The Journal of clinical endocrinology and metabolism 1981;52(4):759-64.
1980: Stephen Kemp; R L Hintz
The action of somatomedin on glycosaminoglycan synthesis in cultured chick chondrocytes.
Endocrinology 1980;106(3):744-9.
1979: A C Stoolmiller; G Dawson; Stephen Kemp; M Schachner
Synthesis of glycosphingolipids in mouse glial tumors.
Journal of neurochemistry 1979;32(2):637-41.
1976: Stephen Kemp; A C Stoolmiller
Biosynthesis of glycosphingolipids in cultured mouse neuroblastoma cells. Precursor-product relationships among sialoglycosphingolipids.
The Journal of biological chemistry 1976;251(23):7626-31.
1976: Stephen Kemp; A C Stoolmiller
Studies on the biosynthesis of glyco-sphingolipids in cultured mouse neuroblastoma cells: characterization and acceptor specificities of N-acetylneuraminyl- and N-acetylgalactosaminyltransferases.
Journal of neurochemistry 1976;27(3):723-32.
1971: G Dawson; Stephen Kemp; A C Stoolmiller; A Dorfman; J P Kennedy
Biosynthesis of glycosphingolipids by mouse neuroblastoma (NB41A), rat glia (RGC-6) and human glia (CHB-4) in cell culture.
Biochemical and biophysical research communications 1971;44(3):687-94.
1969: S D Adamson; E Herbert; Stephen Kemp
Effects of hemin and other porphyrins on protein synthesis in a reticulocyte lysate cell-free system.
Journal of molecular biology 1969;42(2):247-58.